SynGenSys

Sheffield, United Kingdom

SynGenSys creates product-specific libraries of synthetic genetic parts for next-generation biomedicines.

$2.3M raised

Apr 2024

Seed

Top Investors

Translink

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has SynGenSys raised?

SynGenSys has raised $2.3M in total funding. The most recent round was Seed. The last funding was announced in April 2024.

Who are SynGenSys's investors?

SynGenSys's investors include Translink.

Where is SynGenSys headquartered?

SynGenSys is headquartered in Sheffield, United Kingdom.

What does SynGenSys do?

SynGenSys creates product-specific libraries of synthetic genetic parts for next-generation biomedicines.

What stage is SynGenSys at?

SynGenSys is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 4, 2024.

MLA

"SynGenSys — Funding & Investors." VCBacked, April 4, 2024, https://www.vcbacked.co/company/syngensys. Accessed June 17, 2026.

APA

VCBacked. (2024). SynGenSys — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/syngensys

Wikipedia (cite web)

{{cite web |title=SynGenSys — Funding & Investors |url=https://www.vcbacked.co/company/syngensys |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 4, 2024.